These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 31307965)

  • 1. Comprehensive medication reviews: Optimal delivery setting and recommendations for quality assessment.
    Farhat NM; Farris KB; Patel MR; Cornish L; Choe HM
    J Am Pharm Assoc (2003); 2019; 59(5):642-645. PubMed ID: 31307965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
    Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
    J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of telephonic comprehensive medication reviews on patient outcomes.
    DeZeeuw EA; Coleman AM; Nahata MC
    Am J Manag Care; 2018 Feb; 24(2):e54-e58. PubMed ID: 29461851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting adaptability to improve Medication Therapy Management (MTM) implementation in community pharmacy.
    Hohmeier KC; Wheeler JS; Turner K; Vick JS; Marchetti ML; Crain J; Brookhart A
    Implement Sci; 2019 Nov; 14(1):99. PubMed ID: 31775801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key informant perspectives about telephonic comprehensive medication review services in the United States.
    Anderson EJ; Dhatt H; Vaffis S; Nelson ML; Warholak T; Campbell PJ; Black H; Kolobova I; Axon DR
    J Am Pharm Assoc (2003); 2022; 62(3):817-825.e1. PubMed ID: 35067476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a medication therapy management program in a primary care clinic.
    Bowers BL; Heffern C; Billings S
    J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
    MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
    J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer decision making for using comprehensive medication review services.
    Zhang Y; Doucette WR
    J Am Pharm Assoc (2003); 2019; 59(2):168-177.e5. PubMed ID: 30612919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and implementation of a pharmacist-run comprehensive medication review program in Wisconsin.
    Schoenrock DL; Hartkopf K; Boeckelman C
    Am J Health Syst Pharm; 2016 Dec; 73(23 Supplement 6):S155-S160. PubMed ID: 27864239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home-Based Comprehensive Medication Reviews: Pharmacist's Impact on Drug Therapy Problems in Geriatric Patients.
    Steele KM; Ruisinger JF; Bates J; Prohaska ES; Melton BL; Hipp S
    Consult Pharm; 2016; 31(10):598-605. PubMed ID: 27725070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive medication review recipients' opinions, actions, and information recall.
    Schulte N; Ruisinger JF; Prohaska ES; Steele KM; Melton BL
    J Am Pharm Assoc (2003); 2017; 57(3):407-411. PubMed ID: 28285066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality.
    Academy of Managed Care Pharmacy ; American Pharmacists Association
    J Am Pharm Assoc (2003); 2014; 54(3):228-40. PubMed ID: 24770440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A checklist for a consistent, comprehensive medication review.
    Vaffis S; Dhatt H; Anderson E; Le D; Campbell PJ; Nelson M; Black H; Kolobova I; Axon DR; Warholak T
    J Am Pharm Assoc (2003); 2023; 63(5):1504-1507.e1. PubMed ID: 37394060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Potentially Drug-Related Patient-Reported Common Symptoms Assessed During Clinical Medication Reviews: A Cross-Sectional Observational Study.
    Schoenmakers TW; Teichert M; Wensing M; de Smet PA
    Drug Saf; 2017 May; 40(5):419-430. PubMed ID: 28205099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.